Right	O
Cervical	O
Vagotomy	B:C0394374
Aggravates	O
Viral	O
Myocarditis	I:C0276138
in	O
Mice	O
Via	O
the	O
Cholinergic	O
Anti-inflammatory	O
Pathway	O

Right	O
Cervical	O
Vagotomy	O
Aggravates	B:C0541889
Viral	O
Myocarditis	I:C0276138
in	O
Mice	O
Via	O
the	O
Cholinergic	O
Anti-inflammatory	O
Pathway	O

Right	O
Cervical	O
Vagotomy	O
Aggravates	O
Viral	B:C0276138
Myocarditis	I:C0276138
in	O
Mice	O
Via	O
the	O
Cholinergic	O
Anti-inflammatory	O
Pathway	O

Right	O
Cervical	O
Vagotomy	O
Aggravates	O
Viral	O
Myocarditis	I:C0276138
in	O
Mice	B:C0025929
Via	O
the	O
Cholinergic	O
Anti-inflammatory	O
Pathway	O

Right	O
Cervical	O
Vagotomy	O
Aggravates	O
Viral	O
Myocarditis	I:C0276138
in	O
Mice	O
Via	O
the	O
Cholinergic	O
Anti-inflammatory	B:C0002773
Pathway	O

Right	O
Cervical	O
Vagotomy	O
Aggravates	O
Viral	O
Myocarditis	I:C0276138
in	O
Mice	O
Via	O
the	O
Cholinergic	O
Anti-inflammatory	O
Pathway	B:C1704259

The	O
autonomic	B:C4016022
nervous	I:C4016022
system	I:C4016022
dysfunction	I:C4016022
with	O
increased	O
sympathetic	I:C1372664
activity	I:C1372664
and	O
withdrawal	O
of	O
vagal	O
activity	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
viral	O
myocarditis	I:C0276138
.	O

The	O
autonomic	O
nervous	I:C4016022
system	I:C4016022
dysfunction	I:C4016022
with	O
increased	B:C1372664
sympathetic	I:C1372664
activity	I:C1372664
and	O
withdrawal	O
of	O
vagal	O
activity	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
viral	O
myocarditis	I:C0276138
.	O

The	O
autonomic	O
nervous	I:C4016022
system	I:C4016022
dysfunction	I:C4016022
with	O
increased	O
sympathetic	I:C1372664
activity	I:C1372664
and	O
withdrawal	O
of	O
vagal	B:C0175551
activity	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
viral	O
myocarditis	I:C0276138
.	O

The	O
autonomic	O
nervous	I:C4016022
system	I:C4016022
dysfunction	I:C4016022
with	O
increased	O
sympathetic	I:C1372664
activity	I:C1372664
and	O
withdrawal	O
of	O
vagal	O
activity	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	B:C0699748
of	O
viral	O
myocarditis	I:C0276138
.	O

The	O
autonomic	O
nervous	I:C4016022
system	I:C4016022
dysfunction	I:C4016022
with	O
increased	O
sympathetic	I:C1372664
activity	I:C1372664
and	O
withdrawal	O
of	O
vagal	O
activity	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
viral	B:C0276138
myocarditis	I:C0276138
.	O

The	O
vagus	B:C0042276
nerve	I:C0042276
can	O
modulate	O
the	O
immune	O
response	I:C0301872
and	O
control	O
inflammation	O
through	O
a	O
'	O
cholinergic	O
anti-inflammatory	O
pathway	O
'	O
dependent	O
on	O
the	O
α7	O
-	I:C0051334
nicotinic	I:C0051334
acetylcholine	I:C0051334
receptor	I:C0051334
(	O
α7nAChR	O
)	O
.	O

The	O
vagus	O
nerve	I:C0042276
can	O
modulate	B:C0443264
the	O
immune	O
response	I:C0301872
and	O
control	O
inflammation	O
through	O
a	O
'	O
cholinergic	O
anti-inflammatory	O
pathway	O
'	O
dependent	O
on	O
the	O
α7	O
-	I:C0051334
nicotinic	I:C0051334
acetylcholine	I:C0051334
receptor	I:C0051334
(	O
α7nAChR	O
)	O
.	O

The	O
vagus	O
nerve	I:C0042276
can	O
modulate	O
the	O
immune	B:C0301872
response	I:C0301872
and	O
control	O
inflammation	O
through	O
a	O
'	O
cholinergic	O
anti-inflammatory	O
pathway	O
'	O
dependent	O
on	O
the	O
α7	O
-	I:C0051334
nicotinic	I:C0051334
acetylcholine	I:C0051334
receptor	I:C0051334
(	O
α7nAChR	O
)	O
.	O

The	O
vagus	O
nerve	I:C0042276
can	O
modulate	O
the	O
immune	O
response	I:C0301872
and	O
control	O
inflammation	B:C0021368
through	O
a	O
'	O
cholinergic	O
anti-inflammatory	O
pathway	O
'	O
dependent	O
on	O
the	O
α7	O
-	I:C0051334
nicotinic	I:C0051334
acetylcholine	I:C0051334
receptor	I:C0051334
(	O
α7nAChR	O
)	O
.	O

The	O
vagus	O
nerve	I:C0042276
can	O
modulate	O
the	O
immune	O
response	I:C0301872
and	O
control	O
inflammation	O
through	O
a	O
'	O
cholinergic	O
anti-inflammatory	B:C0002773
pathway	O
'	O
dependent	O
on	O
the	O
α7	O
-	I:C0051334
nicotinic	I:C0051334
acetylcholine	I:C0051334
receptor	I:C0051334
(	O
α7nAChR	O
)	O
.	O

The	O
vagus	O
nerve	I:C0042276
can	O
modulate	O
the	O
immune	O
response	I:C0301872
and	O
control	O
inflammation	O
through	O
a	O
'	O
cholinergic	O
anti-inflammatory	O
pathway	B:C1704259
'	O
dependent	O
on	O
the	O
α7	O
-	I:C0051334
nicotinic	I:C0051334
acetylcholine	I:C0051334
receptor	I:C0051334
(	O
α7nAChR	O
)	O
.	O

The	O
vagus	O
nerve	I:C0042276
can	O
modulate	O
the	O
immune	O
response	I:C0301872
and	O
control	O
inflammation	O
through	O
a	O
'	O
cholinergic	O
anti-inflammatory	O
pathway	O
'	O
dependent	O
on	O
the	O
α7	B:C0051334
-	I:C0051334
nicotinic	I:C0051334
acetylcholine	I:C0051334
receptor	I:C0051334
(	O
α7nAChR	O
)	O
.	O

The	O
vagus	O
nerve	I:C0042276
can	O
modulate	O
the	O
immune	O
response	I:C0301872
and	O
control	O
inflammation	O
through	O
a	O
'	O
cholinergic	O
anti-inflammatory	O
pathway	O
'	O
dependent	O
on	O
the	O
α7	O
-	I:C0051334
nicotinic	I:C0051334
acetylcholine	I:C0051334
receptor	I:C0051334
(	O
α7nAChR	B:C0051334
)	O
.	O

Although	O
the	O
role	O
of	O
β-	B:C1862288
adrenergic	I:C1862288
stimulation	I:C1862288
on	O
viral	O
myocarditis	I:C0276138
has	O
been	O
investigated	O
in	O
our	O
pervious	O
studies	O
,	O
the	O
direct	O
effect	O
of	O
vagal	O
tone	O
in	O
this	O
setting	O
has	O
not	O
been	O
yet	O
studied	O
.	O

Although	O
the	O
role	O
of	O
β-	O
adrenergic	I:C1862288
stimulation	I:C1862288
on	O
viral	B:C0276138
myocarditis	I:C0276138
has	O
been	O
investigated	O
in	O
our	O
pervious	O
studies	O
,	O
the	O
direct	O
effect	O
of	O
vagal	O
tone	O
in	O
this	O
setting	O
has	O
not	O
been	O
yet	O
studied	O
.	O

Although	O
the	O
role	O
of	O
β-	O
adrenergic	I:C1862288
stimulation	I:C1862288
on	O
viral	O
myocarditis	I:C0276138
has	O
been	O
investigated	O
in	O
our	O
pervious	O
studies	B:C2603343
,	O
the	O
direct	O
effect	O
of	O
vagal	O
tone	O
in	O
this	O
setting	O
has	O
not	O
been	O
yet	O
studied	O
.	O

Although	O
the	O
role	O
of	O
β-	O
adrenergic	I:C1862288
stimulation	I:C1862288
on	O
viral	O
myocarditis	I:C0276138
has	O
been	O
investigated	O
in	O
our	O
pervious	O
studies	O
,	O
the	O
direct	O
effect	O
of	O
vagal	O
tone	O
in	O
this	O
setting	O
has	O
not	O
been	O
yet	O
studied	B:C2603343
.	O

Therefore	O
,	O
in	O
the	O
present	O
study	B:C2603343
,	O
we	O
investigated	O
the	O
effect	O
s	O
of	O
cervical	O
vagotomy	O
in	O
a	O
murine	O
model	O
of	O
viral	O
myocarditis	I:C0276138
.	O

Therefore	O
,	O
in	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
effect	O
s	O
of	O
cervical	B:C0205064
vagotomy	O
in	O
a	O
murine	O
model	O
of	O
viral	O
myocarditis	I:C0276138
.	O

Therefore	O
,	O
in	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
effect	O
s	O
of	O
cervical	O
vagotomy	B:C0394374
in	O
a	O
murine	O
model	O
of	O
viral	O
myocarditis	I:C0276138
.	O

Therefore	O
,	O
in	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
effect	O
s	O
of	O
cervical	O
vagotomy	O
in	O
a	O
murine	B:C1007978
model	O
of	O
viral	O
myocarditis	I:C0276138
.	O

Therefore	O
,	O
in	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
effect	O
s	O
of	O
cervical	O
vagotomy	O
in	O
a	O
murine	O
model	B:C0012644
of	O
viral	O
myocarditis	I:C0276138
.	O

Therefore	O
,	O
in	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
effect	O
s	O
of	O
cervical	O
vagotomy	O
in	O
a	O
murine	O
model	O
of	O
viral	B:C0276138
myocarditis	I:C0276138
.	O

In	O
a	O
coxsackievirus	O
B3	O
murine	B:C1007978
myocarditis	O
model	O
(	O
Balb	O
/	I:C0025919
c	I:C0025919
)	O
,	O
effects	O
of	O
right	O
cervical	O
vagotomy	O
and	O
nAChR	O
agonist	I:C0242948
nicotine	I:C0242948
on	O
echocardiography	O
,	O
myocardial	O
histopathology	O
,	O
viral	O
RNA	I:C0035736
,	O
and	O
proinflammatory	O
cytokine	O
levels	O
were	O
studied	O
.	O

In	O
a	O
coxsackievirus	O
B3	O
murine	O
myocarditis	B:C0027059
model	O
(	O
Balb	O
/	I:C0025919
c	I:C0025919
)	O
,	O
effects	O
of	O
right	O
cervical	O
vagotomy	O
and	O
nAChR	O
agonist	I:C0242948
nicotine	I:C0242948
on	O
echocardiography	O
,	O
myocardial	O
histopathology	O
,	O
viral	O
RNA	I:C0035736
,	O
and	O
proinflammatory	O
cytokine	O
levels	O
were	O
studied	O
.	O

In	O
a	O
coxsackievirus	O
B3	O
murine	O
myocarditis	O
model	B:C0012644
(	O
Balb	O
/	I:C0025919
c	I:C0025919
)	O
,	O
effects	O
of	O
right	O
cervical	O
vagotomy	O
and	O
nAChR	O
agonist	I:C0242948
nicotine	I:C0242948
on	O
echocardiography	O
,	O
myocardial	O
histopathology	O
,	O
viral	O
RNA	I:C0035736
,	O
and	O
proinflammatory	O
cytokine	O
levels	O
were	O
studied	O
.	O

In	O
a	O
coxsackievirus	O
B3	O
murine	O
myocarditis	O
model	O
(	O
Balb	B:C0025919
/	I:C0025919
c	I:C0025919
)	O
,	O
effects	O
of	O
right	O
cervical	O
vagotomy	O
and	O
nAChR	O
agonist	I:C0242948
nicotine	I:C0242948
on	O
echocardiography	O
,	O
myocardial	O
histopathology	O
,	O
viral	O
RNA	I:C0035736
,	O
and	O
proinflammatory	O
cytokine	O
levels	O
were	O
studied	O
.	O

In	O
a	O
coxsackievirus	O
B3	O
murine	O
myocarditis	O
model	O
(	O
Balb	O
/	I:C0025919
c	I:C0025919
)	O
,	O
effects	O
of	O
right	O
cervical	O
vagotomy	B:C0394374
and	O
nAChR	O
agonist	I:C0242948
nicotine	I:C0242948
on	O
echocardiography	O
,	O
myocardial	O
histopathology	O
,	O
viral	O
RNA	I:C0035736
,	O
and	O
proinflammatory	O
cytokine	O
levels	O
were	O
studied	O
.	O

In	O
a	O
coxsackievirus	O
B3	O
murine	O
myocarditis	O
model	O
(	O
Balb	O
/	I:C0025919
c	I:C0025919
)	O
,	O
effects	O
of	O
right	O
cervical	O
vagotomy	O
and	O
nAChR	B:C0242948
agonist	I:C0242948
nicotine	I:C0242948
on	O
echocardiography	O
,	O
myocardial	O
histopathology	O
,	O
viral	O
RNA	I:C0035736
,	O
and	O
proinflammatory	O
cytokine	O
levels	O
were	O
studied	O
.	O

In	O
a	O
coxsackievirus	O
B3	O
murine	O
myocarditis	O
model	O
(	O
Balb	O
/	I:C0025919
c	I:C0025919
)	O
,	O
effects	O
of	O
right	O
cervical	O
vagotomy	O
and	O
nAChR	O
agonist	I:C0242948
nicotine	I:C0242948
on	O
echocardiography	B:C0013516
,	O
myocardial	O
histopathology	O
,	O
viral	O
RNA	I:C0035736
,	O
and	O
proinflammatory	O
cytokine	O
levels	O
were	O
studied	O
.	O

In	O
a	O
coxsackievirus	O
B3	O
murine	O
myocarditis	O
model	O
(	O
Balb	O
/	I:C0025919
c	I:C0025919
)	O
,	O
effects	O
of	O
right	O
cervical	O
vagotomy	O
and	O
nAChR	O
agonist	I:C0242948
nicotine	I:C0242948
on	O
echocardiography	O
,	O
myocardial	B:C1522564
histopathology	O
,	O
viral	O
RNA	I:C0035736
,	O
and	O
proinflammatory	O
cytokine	O
levels	O
were	O
studied	O
.	O

In	O
a	O
coxsackievirus	O
B3	O
murine	O
myocarditis	O
model	O
(	O
Balb	O
/	I:C0025919
c	I:C0025919
)	O
,	O
effects	O
of	O
right	O
cervical	O
vagotomy	O
and	O
nAChR	O
agonist	I:C0242948
nicotine	I:C0242948
on	O
echocardiography	O
,	O
myocardial	O
histopathology	B:C2985639
,	O
viral	O
RNA	I:C0035736
,	O
and	O
proinflammatory	O
cytokine	O
levels	O
were	O
studied	O
.	O

In	O
a	O
coxsackievirus	O
B3	O
murine	O
myocarditis	O
model	O
(	O
Balb	O
/	I:C0025919
c	I:C0025919
)	O
,	O
effects	O
of	O
right	O
cervical	O
vagotomy	O
and	O
nAChR	O
agonist	I:C0242948
nicotine	I:C0242948
on	O
echocardiography	O
,	O
myocardial	O
histopathology	O
,	O
viral	B:C0035736
RNA	I:C0035736
,	O
and	O
proinflammatory	O
cytokine	O
levels	O
were	O
studied	O
.	O

In	O
a	O
coxsackievirus	O
B3	O
murine	O
myocarditis	O
model	O
(	O
Balb	O
/	I:C0025919
c	I:C0025919
)	O
,	O
effects	O
of	O
right	O
cervical	O
vagotomy	O
and	O
nAChR	O
agonist	I:C0242948
nicotine	I:C0242948
on	O
echocardiography	O
,	O
myocardial	O
histopathology	O
,	O
viral	O
RNA	I:C0035736
,	O
and	O
proinflammatory	O
cytokine	B:C0079189
levels	O
were	O
studied	O
.	O

In	O
a	O
coxsackievirus	O
B3	O
murine	O
myocarditis	O
model	O
(	O
Balb	O
/	I:C0025919
c	I:C0025919
)	O
,	O
effects	O
of	O
right	O
cervical	O
vagotomy	O
and	O
nAChR	O
agonist	I:C0242948
nicotine	I:C0242948
on	O
echocardiography	O
,	O
myocardial	O
histopathology	O
,	O
viral	O
RNA	I:C0035736
,	O
and	O
proinflammatory	O
cytokine	O
levels	O
were	O
studied	B:C2603343
.	O

We	O
found	O
that	O
right	O
cervical	O
vagotomy	B:C0394374
inhibited	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
,	O
aggravated	O
myocardial	O
lesions	I:C0577812
,	O
up	O
-	I:C0041904
regulated	I:C0041904
the	O
expression	O
of	O
TNF-α	O
,	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
,	O
and	O
IL	O
-	I:C0021760
6	I:C0021760
,	O
and	O
worsened	O
the	O
impaired	O
left	O
ventricular	I:C0080310
function	I:C0080310
in	O
murine	O
viral	O
myocarditis	I:C0276138
,	O
and	O
these	O
changes	O
were	O
reversed	O
by	O
co-treatment	O
with	O
nicotine	O
by	O
activating	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
.	O

We	O
found	O
that	O
right	O
cervical	O
vagotomy	O
inhibited	O
the	O
cholinergic	O
anti-inflammatory	B:C0002773
pathway	O
,	O
aggravated	O
myocardial	O
lesions	I:C0577812
,	O
up	O
-	I:C0041904
regulated	I:C0041904
the	O
expression	O
of	O
TNF-α	O
,	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
,	O
and	O
IL	O
-	I:C0021760
6	I:C0021760
,	O
and	O
worsened	O
the	O
impaired	O
left	O
ventricular	I:C0080310
function	I:C0080310
in	O
murine	O
viral	O
myocarditis	I:C0276138
,	O
and	O
these	O
changes	O
were	O
reversed	O
by	O
co-treatment	O
with	O
nicotine	O
by	O
activating	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
.	O

We	O
found	O
that	O
right	O
cervical	O
vagotomy	O
inhibited	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	B:C1704259
,	O
aggravated	O
myocardial	O
lesions	I:C0577812
,	O
up	O
-	I:C0041904
regulated	I:C0041904
the	O
expression	O
of	O
TNF-α	O
,	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
,	O
and	O
IL	O
-	I:C0021760
6	I:C0021760
,	O
and	O
worsened	O
the	O
impaired	O
left	O
ventricular	I:C0080310
function	I:C0080310
in	O
murine	O
viral	O
myocarditis	I:C0276138
,	O
and	O
these	O
changes	O
were	O
reversed	O
by	O
co-treatment	O
with	O
nicotine	O
by	O
activating	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
.	O

We	O
found	O
that	O
right	O
cervical	O
vagotomy	O
inhibited	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
,	O
aggravated	B:C0151885
myocardial	O
lesions	I:C0577812
,	O
up	O
-	I:C0041904
regulated	I:C0041904
the	O
expression	O
of	O
TNF-α	O
,	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
,	O
and	O
IL	O
-	I:C0021760
6	I:C0021760
,	O
and	O
worsened	O
the	O
impaired	O
left	O
ventricular	I:C0080310
function	I:C0080310
in	O
murine	O
viral	O
myocarditis	I:C0276138
,	O
and	O
these	O
changes	O
were	O
reversed	O
by	O
co-treatment	O
with	O
nicotine	O
by	O
activating	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
.	O

We	O
found	O
that	O
right	O
cervical	O
vagotomy	O
inhibited	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
,	O
aggravated	O
myocardial	B:C0577812
lesions	I:C0577812
,	O
up	O
-	I:C0041904
regulated	I:C0041904
the	O
expression	O
of	O
TNF-α	O
,	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
,	O
and	O
IL	O
-	I:C0021760
6	I:C0021760
,	O
and	O
worsened	O
the	O
impaired	O
left	O
ventricular	I:C0080310
function	I:C0080310
in	O
murine	O
viral	O
myocarditis	I:C0276138
,	O
and	O
these	O
changes	O
were	O
reversed	O
by	O
co-treatment	O
with	O
nicotine	O
by	O
activating	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
.	O

We	O
found	O
that	O
right	O
cervical	O
vagotomy	O
inhibited	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
,	O
aggravated	O
myocardial	O
lesions	I:C0577812
,	O
up	B:C0041904
-	I:C0041904
regulated	I:C0041904
the	O
expression	O
of	O
TNF-α	O
,	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
,	O
and	O
IL	O
-	I:C0021760
6	I:C0021760
,	O
and	O
worsened	O
the	O
impaired	O
left	O
ventricular	I:C0080310
function	I:C0080310
in	O
murine	O
viral	O
myocarditis	I:C0276138
,	O
and	O
these	O
changes	O
were	O
reversed	O
by	O
co-treatment	O
with	O
nicotine	O
by	O
activating	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
.	O

We	O
found	O
that	O
right	O
cervical	O
vagotomy	O
inhibited	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
,	O
aggravated	O
myocardial	O
lesions	I:C0577812
,	O
up	O
-	I:C0041904
regulated	I:C0041904
the	O
expression	B:C1171362
of	O
TNF-α	O
,	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
,	O
and	O
IL	O
-	I:C0021760
6	I:C0021760
,	O
and	O
worsened	O
the	O
impaired	O
left	O
ventricular	I:C0080310
function	I:C0080310
in	O
murine	O
viral	O
myocarditis	I:C0276138
,	O
and	O
these	O
changes	O
were	O
reversed	O
by	O
co-treatment	O
with	O
nicotine	O
by	O
activating	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
.	O

We	O
found	O
that	O
right	O
cervical	O
vagotomy	O
inhibited	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
,	O
aggravated	O
myocardial	O
lesions	I:C0577812
,	O
up	O
-	I:C0041904
regulated	I:C0041904
the	O
expression	O
of	O
TNF-α	B:C1456820
,	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
,	O
and	O
IL	O
-	I:C0021760
6	I:C0021760
,	O
and	O
worsened	O
the	O
impaired	O
left	O
ventricular	I:C0080310
function	I:C0080310
in	O
murine	O
viral	O
myocarditis	I:C0276138
,	O
and	O
these	O
changes	O
were	O
reversed	O
by	O
co-treatment	O
with	O
nicotine	O
by	O
activating	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
.	O

We	O
found	O
that	O
right	O
cervical	O
vagotomy	O
inhibited	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
,	O
aggravated	O
myocardial	O
lesions	I:C0577812
,	O
up	O
-	I:C0041904
regulated	I:C0041904
the	O
expression	O
of	O
TNF-α	O
,	O
IL	B:C0021753
-	I:C0021753
1	I:C0021753
β	I:C0021753
,	O
and	O
IL	O
-	I:C0021760
6	I:C0021760
,	O
and	O
worsened	O
the	O
impaired	O
left	O
ventricular	I:C0080310
function	I:C0080310
in	O
murine	O
viral	O
myocarditis	I:C0276138
,	O
and	O
these	O
changes	O
were	O
reversed	O
by	O
co-treatment	O
with	O
nicotine	O
by	O
activating	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
.	O

We	O
found	O
that	O
right	O
cervical	O
vagotomy	O
inhibited	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
,	O
aggravated	O
myocardial	O
lesions	I:C0577812
,	O
up	O
-	I:C0041904
regulated	I:C0041904
the	O
expression	O
of	O
TNF-α	O
,	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
,	O
and	O
IL	B:C0021760
-	I:C0021760
6	I:C0021760
,	O
and	O
worsened	O
the	O
impaired	O
left	O
ventricular	I:C0080310
function	I:C0080310
in	O
murine	O
viral	O
myocarditis	I:C0276138
,	O
and	O
these	O
changes	O
were	O
reversed	O
by	O
co-treatment	O
with	O
nicotine	O
by	O
activating	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
.	O

We	O
found	O
that	O
right	O
cervical	O
vagotomy	O
inhibited	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
,	O
aggravated	O
myocardial	O
lesions	I:C0577812
,	O
up	O
-	I:C0041904
regulated	I:C0041904
the	O
expression	O
of	O
TNF-α	O
,	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
,	O
and	O
IL	O
-	I:C0021760
6	I:C0021760
,	O
and	O
worsened	O
the	O
impaired	O
left	B:C0080310
ventricular	I:C0080310
function	I:C0080310
in	O
murine	O
viral	O
myocarditis	I:C0276138
,	O
and	O
these	O
changes	O
were	O
reversed	O
by	O
co-treatment	O
with	O
nicotine	O
by	O
activating	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
.	O

We	O
found	O
that	O
right	O
cervical	O
vagotomy	O
inhibited	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
,	O
aggravated	O
myocardial	O
lesions	I:C0577812
,	O
up	O
-	I:C0041904
regulated	I:C0041904
the	O
expression	O
of	O
TNF-α	O
,	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
,	O
and	O
IL	O
-	I:C0021760
6	I:C0021760
,	O
and	O
worsened	O
the	O
impaired	O
left	O
ventricular	I:C0080310
function	I:C0080310
in	O
murine	B:C1007978
viral	O
myocarditis	I:C0276138
,	O
and	O
these	O
changes	O
were	O
reversed	O
by	O
co-treatment	O
with	O
nicotine	O
by	O
activating	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
.	O

We	O
found	O
that	O
right	O
cervical	O
vagotomy	O
inhibited	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
,	O
aggravated	O
myocardial	O
lesions	I:C0577812
,	O
up	O
-	I:C0041904
regulated	I:C0041904
the	O
expression	O
of	O
TNF-α	O
,	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
,	O
and	O
IL	O
-	I:C0021760
6	I:C0021760
,	O
and	O
worsened	O
the	O
impaired	O
left	O
ventricular	I:C0080310
function	I:C0080310
in	O
murine	O
viral	B:C0276138
myocarditis	I:C0276138
,	O
and	O
these	O
changes	O
were	O
reversed	O
by	O
co-treatment	O
with	O
nicotine	O
by	O
activating	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
.	O

We	O
found	O
that	O
right	O
cervical	O
vagotomy	O
inhibited	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
,	O
aggravated	O
myocardial	O
lesions	I:C0577812
,	O
up	O
-	I:C0041904
regulated	I:C0041904
the	O
expression	O
of	O
TNF-α	O
,	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
,	O
and	O
IL	O
-	I:C0021760
6	I:C0021760
,	O
and	O
worsened	O
the	O
impaired	O
left	O
ventricular	I:C0080310
function	I:C0080310
in	O
murine	O
viral	O
myocarditis	I:C0276138
,	O
and	O
these	O
changes	O
were	O
reversed	O
by	O
co-treatment	O
with	O
nicotine	B:C0028040
by	O
activating	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
.	O

We	O
found	O
that	O
right	O
cervical	O
vagotomy	O
inhibited	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
,	O
aggravated	O
myocardial	O
lesions	I:C0577812
,	O
up	O
-	I:C0041904
regulated	I:C0041904
the	O
expression	O
of	O
TNF-α	O
,	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
,	O
and	O
IL	O
-	I:C0021760
6	I:C0021760
,	O
and	O
worsened	O
the	O
impaired	O
left	O
ventricular	I:C0080310
function	I:C0080310
in	O
murine	O
viral	O
myocarditis	I:C0276138
,	O
and	O
these	O
changes	O
were	O
reversed	O
by	O
co-treatment	O
with	O
nicotine	O
by	O
activating	O
the	O
cholinergic	O
anti-inflammatory	B:C0002773
pathway	O
.	O

We	O
found	O
that	O
right	O
cervical	O
vagotomy	O
inhibited	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	O
,	O
aggravated	O
myocardial	O
lesions	I:C0577812
,	O
up	O
-	I:C0041904
regulated	I:C0041904
the	O
expression	O
of	O
TNF-α	O
,	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
,	O
and	O
IL	O
-	I:C0021760
6	I:C0021760
,	O
and	O
worsened	O
the	O
impaired	O
left	O
ventricular	I:C0080310
function	I:C0080310
in	O
murine	O
viral	O
myocarditis	I:C0276138
,	O
and	O
these	O
changes	O
were	O
reversed	O
by	O
co-treatment	O
with	O
nicotine	O
by	O
activating	O
the	O
cholinergic	O
anti-inflammatory	O
pathway	B:C1704259
.	O

These	O
results	O
indicate	O
that	O
vagal	B:C0175551
nerve	I:C0175551
plays	O
an	O
important	O
role	O
in	O
mediating	O
the	O
anti-inflammatory	O
effect	O
in	O
viral	O
myocarditis	I:C0276138
,	O
and	O
that	O
cholinergic	O
stimulation	O
with	O
nicotine	O
also	O
plays	O
its	O
peripheral	O
anti-inflammatory	O
role	O
relying	O
on	O
α7nAChR	O
,	O
without	O
requirement	O
for	O
the	O
integrity	O
of	O
vagal	O
nerve	I:C0175551
in	O
the	O
model	O
.	O

These	O
results	O
indicate	O
that	O
vagal	O
nerve	I:C0175551
plays	O
an	O
important	O
role	O
in	O
mediating	O
the	O
anti-inflammatory	B:C0002773
effect	O
in	O
viral	O
myocarditis	I:C0276138
,	O
and	O
that	O
cholinergic	O
stimulation	O
with	O
nicotine	O
also	O
plays	O
its	O
peripheral	O
anti-inflammatory	O
role	O
relying	O
on	O
α7nAChR	O
,	O
without	O
requirement	O
for	O
the	O
integrity	O
of	O
vagal	O
nerve	I:C0175551
in	O
the	O
model	O
.	O

These	O
results	O
indicate	O
that	O
vagal	O
nerve	I:C0175551
plays	O
an	O
important	O
role	O
in	O
mediating	O
the	O
anti-inflammatory	O
effect	O
in	O
viral	B:C0276138
myocarditis	I:C0276138
,	O
and	O
that	O
cholinergic	O
stimulation	O
with	O
nicotine	O
also	O
plays	O
its	O
peripheral	O
anti-inflammatory	O
role	O
relying	O
on	O
α7nAChR	O
,	O
without	O
requirement	O
for	O
the	O
integrity	O
of	O
vagal	O
nerve	I:C0175551
in	O
the	O
model	O
.	O

These	O
results	O
indicate	O
that	O
vagal	O
nerve	I:C0175551
plays	O
an	O
important	O
role	O
in	O
mediating	O
the	O
anti-inflammatory	O
effect	O
in	O
viral	O
myocarditis	I:C0276138
,	O
and	O
that	O
cholinergic	O
stimulation	B:C1292856
with	O
nicotine	O
also	O
plays	O
its	O
peripheral	O
anti-inflammatory	O
role	O
relying	O
on	O
α7nAChR	O
,	O
without	O
requirement	O
for	O
the	O
integrity	O
of	O
vagal	O
nerve	I:C0175551
in	O
the	O
model	O
.	O

These	O
results	O
indicate	O
that	O
vagal	O
nerve	I:C0175551
plays	O
an	O
important	O
role	O
in	O
mediating	O
the	O
anti-inflammatory	O
effect	O
in	O
viral	O
myocarditis	I:C0276138
,	O
and	O
that	O
cholinergic	O
stimulation	O
with	O
nicotine	B:C0028040
also	O
plays	O
its	O
peripheral	O
anti-inflammatory	O
role	O
relying	O
on	O
α7nAChR	O
,	O
without	O
requirement	O
for	O
the	O
integrity	O
of	O
vagal	O
nerve	I:C0175551
in	O
the	O
model	O
.	O

These	O
results	O
indicate	O
that	O
vagal	O
nerve	I:C0175551
plays	O
an	O
important	O
role	O
in	O
mediating	O
the	O
anti-inflammatory	O
effect	O
in	O
viral	O
myocarditis	I:C0276138
,	O
and	O
that	O
cholinergic	O
stimulation	O
with	O
nicotine	O
also	O
plays	O
its	O
peripheral	B:C0205100
anti-inflammatory	O
role	O
relying	O
on	O
α7nAChR	O
,	O
without	O
requirement	O
for	O
the	O
integrity	O
of	O
vagal	O
nerve	I:C0175551
in	O
the	O
model	O
.	O

These	O
results	O
indicate	O
that	O
vagal	O
nerve	I:C0175551
plays	O
an	O
important	O
role	O
in	O
mediating	O
the	O
anti-inflammatory	O
effect	O
in	O
viral	O
myocarditis	I:C0276138
,	O
and	O
that	O
cholinergic	O
stimulation	O
with	O
nicotine	O
also	O
plays	O
its	O
peripheral	O
anti-inflammatory	B:C0002773
role	O
relying	O
on	O
α7nAChR	O
,	O
without	O
requirement	O
for	O
the	O
integrity	O
of	O
vagal	O
nerve	I:C0175551
in	O
the	O
model	O
.	O

These	O
results	O
indicate	O
that	O
vagal	O
nerve	I:C0175551
plays	O
an	O
important	O
role	O
in	O
mediating	O
the	O
anti-inflammatory	O
effect	O
in	O
viral	O
myocarditis	I:C0276138
,	O
and	O
that	O
cholinergic	O
stimulation	O
with	O
nicotine	O
also	O
plays	O
its	O
peripheral	O
anti-inflammatory	O
role	O
relying	O
on	O
α7nAChR	B:C0051334
,	O
without	O
requirement	O
for	O
the	O
integrity	O
of	O
vagal	O
nerve	I:C0175551
in	O
the	O
model	O
.	O

These	O
results	O
indicate	O
that	O
vagal	O
nerve	I:C0175551
plays	O
an	O
important	O
role	O
in	O
mediating	O
the	O
anti-inflammatory	O
effect	O
in	O
viral	O
myocarditis	I:C0276138
,	O
and	O
that	O
cholinergic	O
stimulation	O
with	O
nicotine	O
also	O
plays	O
its	O
peripheral	O
anti-inflammatory	O
role	O
relying	O
on	O
α7nAChR	O
,	O
without	O
requirement	O
for	O
the	O
integrity	O
of	O
vagal	B:C0175551
nerve	I:C0175551
in	O
the	O
model	O
.	O

These	O
results	O
indicate	O
that	O
vagal	O
nerve	I:C0175551
plays	O
an	O
important	O
role	O
in	O
mediating	O
the	O
anti-inflammatory	O
effect	O
in	O
viral	O
myocarditis	I:C0276138
,	O
and	O
that	O
cholinergic	O
stimulation	O
with	O
nicotine	O
also	O
plays	O
its	O
peripheral	O
anti-inflammatory	O
role	O
relying	O
on	O
α7nAChR	O
,	O
without	O
requirement	O
for	O
the	O
integrity	O
of	O
vagal	O
nerve	I:C0175551
in	O
the	O
model	B:C0012644
.	O

The	O
findings	B:C0243095
suggest	O
that	O
vagus	O
nerve	I:C0042276
stimulation	O
mediated	O
inhibition	O
of	O
the	O
inflammatory	O
processes	O
likely	O
provide	O
important	O
benefits	O
in	O
myocarditis	O
treatment	O
.	O

The	O
findings	O
suggest	O
that	O
vagus	B:C0042276
nerve	I:C0042276
stimulation	O
mediated	O
inhibition	O
of	O
the	O
inflammatory	O
processes	O
likely	O
provide	O
important	O
benefits	O
in	O
myocarditis	O
treatment	O
.	O

The	O
findings	O
suggest	O
that	O
vagus	O
nerve	I:C0042276
stimulation	B:C1292856
mediated	O
inhibition	O
of	O
the	O
inflammatory	O
processes	O
likely	O
provide	O
important	O
benefits	O
in	O
myocarditis	O
treatment	O
.	O

The	O
findings	O
suggest	O
that	O
vagus	O
nerve	I:C0042276
stimulation	O
mediated	O
inhibition	O
of	O
the	O
inflammatory	O
processes	O
likely	O
provide	O
important	O
benefits	O
in	O
myocarditis	B:C0027059
treatment	O
.	O

The	O
findings	O
suggest	O
that	O
vagus	O
nerve	I:C0042276
stimulation	O
mediated	O
inhibition	O
of	O
the	O
inflammatory	O
processes	O
likely	O
provide	O
important	O
benefits	O
in	O
myocarditis	O
treatment	B:C0087111
.	O

